Biologic–biologic and biologic–JAK inhibitor combination therapy in refractory systemic autoinflammatory diseases

Seminars in Arthritis and Rheumatism · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles